Anemii, soprovozhdayushchiesya gipoferremiey: vzglyad klinicheskogo farmakologa


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This review is dedicated to the anemia accompanied by hypoferremia. Pathogenetical features of anemia in chronic renal failure and anemia of chronic disease (ACD) require different approaches to the medical correction. The leading role of iron supplements in the treatment of iron deficiency anemia with sufficiently elaborated indications for their use does not admit of doubt. The available evidence base for treatment of ACD is quite contradictory; the decision on the advisability of use of iron supplements requires careful evaluation of clinical symptoms and laboratory data reflecting iron metabolism.

Full Text

Restricted Access

About the authors

S. B Erofeeva

Email: erofsb@mail.ru

A. M Shelukhin

References

  1. Stoltzfus RJ, Dreyfuss ML Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia WHO, 1998.
  2. Smith RE Jr. The Clinical and Economic Burden of Anemia. Am J Manag Care 2010;16:59-66.
  3. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004;104:2263-68.
  4. Kaushansky K, Lichtman M, Beutler E, et al. Williams Hematology, Anemia of Chronic Disease, 2010.
  5. Weiss G, Goodnough LT, Anemia of Chronic Disease N Engl J Med 2005;352:1011-23.
  6. Ganz T, Nemeth E. The Hepcidin-Ferroportin System as a Therapeutic Target in Anemias and Iron Overload Disorders. Hematology Am Soc Hematol Educ Program 2011:538-42.
  7. Hepcidin-Ferroportin: Partners in Iron Balance www.irondisorders.org
  8. Hastka J, Lasserre JJ, Schwarzbeck A, et al. Zinc protoporphyrin in anemia of chronic disorders. Blood 1993;81:1200.
  9. Berry ER, Rambach WA, Alt HL, Del Greco G. Effect of peritoneal dialysis on erythrokinetics and ferrokinetics of azotemic anemia. Trans Am SocArtif Intern Organs 1964;10:415.
  10. Brain MC. The haemolytic-uremic syndrome. Semin Hematol 1969;6:162.
  11. Fisher JW. Mechanism of the anemia of chronic renal failure. 1980;25:106.
  12. Castaldi PA, Gorman DJ, et al. Disordered platelet function in renal disease, in Hemostasis and Thrombosis. Lippincott, Philadelphia, 1987:750.
  13. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency Anaemia BMJ Gut 2000;46(suppl. IV):iv1-iv5.
  14. Corwin HL, Krantz SB. Anemia of the critically ill: Acute anemia of chronic disease. Crit Care Med 2000;28:3098.
  15. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052.
  16. Sears DA. Anemia of chronic disease. Med Clin North Am 1992;76:567. [PMID: 1578957].
  17. Weiss G. Iron and immunity: a doubleedged sword. Eur J Clin Invest 2002; 32(suppl. 1):70-8.
  18. Iron Avidity. Common Phenomenon seen in hemochromatosis patients www.irondisorders. org Autumn 2004:9.
  19. Caro J, Brown S, Miller O, et al. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979;93:449.
  20. Bessman JD, Feinstein DI. Quantitative anisocytosis as a discriminant between iron deficiency and thalassemia minor. Blood 1979;53:288.
  21. Fairbanks VF. Is the peripheral blood film reliable for the diagnosis of iron deficiency anemia. Am J Clin Pathol 1971;55:447.
  22. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and Treatment of Iron Deficiency Anemia: A Gastroenterological Perspective Dig Dis Sci 2010;55:548-59. doi: 10.1007/s10620-009-1108-106.
  23. Aslan D, Gumruk F, Gurgey A, Altay C. Importance of RDW value in differential diagnosis of hypochrome anemias. Am J Hematol 2002;69:31-33.
  24. Bessman JD, Johnson RK. Erythrocyte volume distribution in normal and abnormal subjects. Blood 1975;46:369-79.
  25. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med 1993;44:63.
  26. Ahluwalia N: Diagnostic utility of serum transferrin receptors measurement in assessing iron status. Nutr Rev 1998;56:133.
  27. Provan D. Mechanisms and management of iron deficiency anaemia. Br J Haematol 1999;105(suppl. 1:19.
  28. Matzner Y, Levy S, Grossowicz N, Izak G, Hershko C. Prevalence and causes of anemia in elderly hospitalized patients. Gerontology 1979;25:113-19.
  29. Beaumont C, Beris P, Beuzard Y, Brugnara C. Disorders of iron homeostasis, erythrocytes, erythropoiesis. Chapter 20 Intravenous iron therapy. 2006:421-34.
  30. Physicians' desk reference: PDR. http:// www.pdr.net/drugpages/productlabeling. aspx?mpcode=73080705#section-6
  31. Wheby MS. Effect of iron therapy on serum ferritin levels in iron-deficiency anemia. Blood 1980;56:138.
  32. Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992;7:145-53.
  33. Baer AN, Dessypris EN, Goldwasser E, et al. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987;66:559.
  34. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214-21.
  35. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 2005;149:391-401.
  36. Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander? Arch Intern Med 2003;163:1400-04 [Erratum, Arch Intern Med 2003;163:1820].
  37. Zarychanski R, Houston DS. Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response? CMAJ 2008;179(4). doi: 10.1503/cmaj.071131
  38. Alleyne М, Horne MK, Miller JL. Individualized treatment for iron deficiency anemia in adults Am J Med 2008;121(11): 943-48. doi: 10.1016/j.amjmed.2008. 07.012.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies